#catalog	Pathway	CKmc1	CKmc2	CKmc3	CKmc4	CKmc5	CKmc6	0hmc1	0hmc2	0hmc3	0hmc4	0hmc5	0hmc7	12hmc1	12hmc2	12hmc3	12hmc4	12hmc5	12hmc6	48hmc1	48hmc2	48hmc3	48hmc4	48hmc5	48hmc6
map04138	Autophagy - yeast	7	24	33	34	5	12	8	59	2	4	6	103	0	11	22	3	11	25	89	33	14	116	18	2
map04810	Regulation of actin cytoskeleton	1	0	26	54	6	4	39	161	0	43	8	62	0	41	40	4	21	53	244	84	44	236	71	23
map00572	Arabinogalactan biosynthesis - Mycobacterium	17	11	16	19	3	12	2	1	0	0	2	26	0	0	1	4	3	8	0	0	0	0	0	0
map04260	Cardiac muscle contraction	72	68	137	91	98	81	63	135	153	55	26	258	51	45	47	25	36	49	122	103	65	122	49	36
map04261	Adrenergic signaling in cardiomyocytes	1	0	43	26	4	0	87	275	7	68	21	66	2	89	86	6	26	27	175	107	67	204	69	30
map05230	Central carbon metabolism in cancer	117	215	220	224	68	249	46	108	30	41	39	350	39	29	35	47	72	72	159	105	83	191	82	90
map04020	Calcium signaling pathway	55	28	698	20	107	16	155	468	201	332	88	152	116	333	311	39	65	202	324	159	131	373	137	52
map05111	Biofilm formation - Vibrio cholerae	398	726	828	569	330	775	159	172	150	103	133	872	103	66	205	202	283	144	419	348	401	466	480	295
map04141	Protein processing in endoplasmic reticulum	42	59	67	226	21	76	22	136	14	54	21	204	22	44	40	21	25	129	162	80	54	218	58	22
map00460	Cyanoamino acid metabolism	153	247	255	190	92	262	81	71	28	26	69	421	41	70	112	76	81	95	122	95	120	120	104	70
map04146	Peroxisome	265	479	509	331	204	461	123	241	96	58	93	655	86	67	149	125	169	119	309	220	195	327	223	201
map00220	Arginine biosynthesis	292	634	780	563	215	753	187	177	84	125	163	908	118	34	228	219	264	198	287	329	266	385	300	237
map04940	Type I diabetes mellitus	27	46	63	70	18	66	18	57	10	27	6	109	23	27	22	20	16	15	47	18	16	60	21	24
map00340	Histidine metabolism	291	517	755	416	227	670	112	164	84	122	134	703	84	49	118	173	178	157	269	277	253	375	323	235
map04144	Endocytosis	11	0	23	76	3	3	25	149	0	72	13	107	0	7	69	15	25	42	198	78	78	225	47	18
map04024	cAMP signaling pathway	1	5	73	30	4	1	115	402	2	96	25	72	2	115	184	11	53	90	334	143	96	377	87	44
map04142	Lysosome	18	39	212	65	21	55	34	336	26	175	37	137	11	158	169	2	24	103	148	109	65	182	67	31
map00900	Terpenoid backbone biosynthesis	248	475	550	369	236	503	127	139	78	85	121	658	100	45	120	125	116	159	213	161	206	286	166	168
map05231	Choline metabolism in cancer	8	18	26	35	8	11	17	99	3	43	6	45	8	1	39	9	18	48	125	47	43	137	30	7
map00901	Indole alkaloid biosynthesis	2	0	2	6	2	7	0	0	0	0	0	3	0	0	0	0	0	0	0	0	1	2	0	0
map00903	Limonene and pinene degradation	185	208	375	198	113	272	53	37	83	70	50	344	49	15	35	98	61	64	107	104	90	157	96	97
map00906	Carotenoid biosynthesis	8	37	17	36	7	35	9	12	18	6	6	67	1	2	4	10	7	11	12	20	9	8	3	2
map00908	Zeatin biosynthesis	3	29	35	21	1	30	1	8	9	5	2	36	5	2	7	3	2	5	18	13	15	15	18	4
map00909	Sesquiterpenoid and triterpenoid biosynthesis	9	11	36	17	2	15	0	0	0	0	0	15	0	0	0	0	0	5	15	15	12	13	21	15
map03060	Protein export	239	465	385	440	180	491	91	94	80	90	71	570	66	40	81	101	106	120	219	179	192	235	219	153
map04150	mTOR signaling pathway	1	16	23	29	0	4	28	212	0	24	3	71	0	18	55	1	23	315	153	53	55	189	20	6
map04151	PI3K-Akt signaling pathway	25	42	57	97	12	53	39	214	23	44	23	135	9	46	73	29	30	118	260	113	61	251	63	25
map05120	Epithelial cell signaling in Helicobacter pylori infection	25	71	79	69	16	83	7	60	23	13	7	102	4	1	34	17	28	16	87	53	40	98	50	25
map04152	AMPK signaling pathway	30	67	92	93	28	89	41	108	23	23	28	131	14	63	48	34	34	133	141	75	61	175	60	35
map00590	Arachidonic acid metabolism	19	37	36	34	14	25	11	25	7	4	4	42	2	5	14	9	9	18	44	28	43	56	23	19
map00470	D-Amino acid metabolism	203	461	543	343	204	457	111	142	86	53	125	537	74	58	197	138	131	121	171	210	207	265	168	182
map00350	Tyrosine metabolism	372	555	785	570	281	794	174	209	101	107	193	916	131	82	221	206	228	233	310	268	270	412	231	230
map00230	Purine metabolism	873	1788	1973	1437	601	1735	406	706	373	437	330	2243	265	180	475	440	528	457	850	732	649	1049	913	609
map00591	Linoleic acid metabolism	8	18	13	15	11	13	2	0	6	0	0	20	2	3	1	2	1	11	18	12	26	18	11	12
map01200	Carbon metabolism	1916	3676	4317	2996	1597	3823	1012	1072	557	686	870	5012	672	520	993	1018	1106	1007	1658	1565	1455	1862	1638	1283
map00592	alpha-Linolenic acid metabolism	9	28	51	34	7	31	24	18	3	9	21	78	3	16	31	12	12	24	53	30	29	51	40	25
map04713	Circadian entrainment	1	3	48	10	4	0	71	208	2	79	19	40	2	68	103	8	12	59	125	66	38	178	59	19
map04714	Thermogenesis	295	339	577	359	309	367	186	439	425	191	108	949	121	190	237	127	143	259	399	269	243	455	238	170
map00910	Nitrogen metabolism	295	801	887	600	321	897	220	227	135	178	163	1097	116	78	223	202	265	223	339	321	246	437	343	239
map03070	Bacterial secretion system	559	1131	1274	898	470	1322	318	339	222	191	293	1407	198	127	357	371	491	350	601	515	571	722	608	452
map05130	Pathogenic Escherichia coli infection	49	96	100	152	36	89	43	214	16	61	26	203	17	24	70	31	46	67	289	134	93	301	118	57
map05010	Alzheimer disease	204	209	405	327	209	199	142	542	360	141	61	887	105	167	236	86	100	161	457	250	197	544	167	96
map05131	Shigellosis	60	85	99	165	36	94	40	247	18	79	23	209	19	51	63	28	41	93	271	125	112	275	105	62
map05133	Pertussis	112	200	265	121	122	226	89	105	39	5	91	270	15	59	170	74	88	122	164	166	142	243	176	117
map00360	Phenylalanine metabolism	480	897	1250	710	466	984	252	282	179	171	265	1234	197	94	349	303	241	318	405	359	352	462	355	265
map00240	Pyrimidine metabolism	547	1162	1195	935	418	1189	244	282	177	168	207	1441	204	56	253	266	315	297	463	450	423	574	514	385
map00362	Benzoate degradation	538	874	1241	683	450	962	273	258	168	173	245	1139	191	92	279	320	269	294	464	433	400	651	435	403
map01210	2-Oxocarboxylic acid metabolism	530	1098	1307	786	440	1099	347	344	180	192	274	1313	212	116	360	363	335	343	445	447	373	495	489	345
map05016	Huntington disease	237	245	453	343	208	232	107	356	363	140	68	921	108	176	171	90	94	191	406	214	206	464	173	98
map01212	Fatty acid metabolism	784	1308	1791	976	687	1440	349	453	304	248	314	1802	233	178	435	372	418	391	739	559	640	894	656	578
map04964	Proximal tubule bicarbonate reclamation	25	46	39	27	5	26	20	21	16	14	9	58	1	3	11	12	11	7	22	22	12	20	18	7
map05014	Amyotrophic lateral sclerosis	241	257	444	386	227	247	133	451	358	125	78	975	122	147	192	95	120	205	534	257	229	602	191	122
map04723	Retrograde endocannabinoid signaling	86	42	220	65	75	30	74	208	184	92	36	342	34	115	106	46	24	69	134	70	75	166	89	28
map04724	Glutamatergic synapse	45	101	174	102	41	138	99	226	5	77	48	215	4	83	144	16	64	46	206	92	88	234	109	37
map00920	Sulfur metabolism	564	771	1159	796	358	997	233	282	266	139	172	1297	174	119	254	276	252	241	408	394	338	524	461	292
map04727	GABAergic synapse	45	109	174	109	41	149	74	207	5	56	46	230	4	62	81	14	52	46	161	87	69	180	95	54
map04728	Dopaminergic synapse	6	23	38	47	12	46	29	113	0	13	0	99	0	17	78	5	4	25	84	45	29	109	34	6
map05132	Salmonella infection	93	165	188	243	60	197	59	231	36	52	33	335	34	44	103	47	56	159	348	183	139	350	151	76
map05012	Parkinson disease	215	215	444	349	206	249	96	306	356	115	63	936	106	123	175	89	79	151	294	176	171	373	147	96
map05134	Legionellosis	95	189	212	219	67	212	48	104	30	84	39	304	52	61	77	55	54	98	140	84	84	162	98	42
map00361	Chlorocyclohexane and chlorobenzene degradation	125	181	272	192	80	266	48	54	33	33	57	224	48	25	72	60	37	49	99	78	83	133	75	79
map00120	Primary bile acid biosynthesis	3	20	29	17	7	20	8	26	0	0	7	45	0	0	8	5	5	0	30	24	19	24	10	25
map00121	Secondary bile acid biosynthesis	19	63	65	44	25	63	12	15	4	10	16	62	5	28	11	22	9	14	25	18	22	33	41	20
map00364	Fluorobenzoate degradation	91	140	191	107	81	174	39	34	28	32	51	157	32	20	45	44	26	33	81	85	74	107	62	61
map00480	Glutathione metabolism	514	765	1071	701	338	888	252	296	121	144	206	1132	142	91	271	285	306	297	336	273	318	426	376	277
map04722	Neurotrophin signaling pathway	1	0	5	30	3	1	13	107	0	30	2	48	0	30	39	2	13	14	65	22	42	89	11	6
map05135	Yersinia infection	1	0	0	41	0	6	12	94	0	26	0	53	0	18	32	0	2	37	108	30	39	98	18	15
map00363	Bisphenol degradation	3	1	1	2	6	2	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	0	0
map05017	Spinocerebellar ataxia	35	92	57	87	35	57	41	190	29	44	14	167	11	42	97	18	31	68	199	69	51	247	73	20
map00365	Furfural degradation	4	9	5	5	4	11	12	0	5	18	1	5	18	13	2	21	10	6	0	0	2	20	5	5
map05020	Prion disease	195	166	380	290	190	169	78	318	345	148	73	828	102	120	186	83	72	150	309	175	155	348	139	78
map05142	Chagas disease	17	22	32	47	2	55	15	29	5	12	0	64	0	17	50	1	14	38	49	30	42	58	30	7
map05022	Pathways of neurodegeneration - multiple diseases	240	260	461	400	230	253	176	593	358	166	77	1023	122	169	281	97	139	212	568	287	263	691	200	121
map04726	Serotonergic synapse	5	23	39	39	9	49	22	78	0	14	1	57	0	38	62	5	4	16	92	56	27	90	38	11
map00250	"Alanine, aspartate and glutamate metabolism"	527	1082	1160	863	391	1229	196	270	195	191	221	1520	141	118	255	210	353	279	494	431	399	569	562	353
map00130	Ubiquinone and other terpenoid-quinone biosynthesis	200	300	335	284	126	337	77	106	67	71	67	447	91	38	54	75	98	91	173	141	129	135	173	98
map00010	Glycolysis / Gluconeogenesis	722	1165	1483	1123	489	1360	322	361	258	235	302	1859	237	192	317	333	336	338	572	512	450	602	541	455
map01100	Metabolic pathways	13340	24634	30632	20846	10361	27257	6574	8837	5072	5393	5507	34347	4637	3289	7409	7361	7662	7411	11954	10777	10368	14346	11733	8681
map05143	African trypanosomiasis	15	22	18	23	9	43	2	3	5	2	0	40	0	17	24	1	10	12	23	18	20	12	23	8
map01220	Degradation of aromatic compounds	487	685	1098	662	384	866	239	181	147	192	173	994	173	98	220	244	222	217	368	349	283	525	324	300
map04975	Fat digestion and absorption	107	182	235	109	114	179	39	60	34	33	66	205	32	13	55	50	65	62	97	70	105	154	72	85
map04612	Antigen processing and presentation	18	25	39	84	10	41	9	24	6	26	17	82	7	20	23	9	14	75	44	18	26	46	40	13
map04976	Bile secretion	7	14	58	30	9	6	66	208	4	61	25	47	4	56	74	11	17	47	128	49	26	153	50	20
map00930	Caprolactam degradation	159	213	366	178	129	219	64	39	85	84	47	287	52	67	48	83	77	62	98	101	85	141	88	66
map04978	Mineral absorption	46	111	132	85	39	102	44	65	34	29	34	151	18	32	44	37	35	53	88	57	57	87	30	26
map04979	Cholesterol metabolism	4	12	7	15	3	4	3	52	0	3	1	15	5	0	8	0	1	12	40	21	26	59	10	3
map04971	Gastric acid secretion	1	0	47	24	10	3	70	169	2	61	21	52	2	68	73	6	26	48	134	40	37	120	53	23
map04972	Pancreatic secretion	2	19	48	33	1	27	81	225	2	71	21	64	2	72	84	12	33	19	155	77	55	178	65	31
map04614	Renin-angiotensin system	18	17	39	19	7	31	4	59	2	23	2	39	0	17	15	5	8	10	56	14	26	72	40	12
map05145	Toxoplasmosis	31	43	45	66	18	48	15	53	6	43	18	88	11	8	50	17	16	31	102	50	38	102	46	19
map04970	Salivary secretion	2	22	46	22	1	27	76	191	2	63	21	64	2	89	83	8	19	18	125	59	43	154	55	22
map04613	Neutrophil extracellular trap formation	4	6	16	59	3	7	37	144	9	45	11	65	7	42	61	13	15	45	154	50	44	144	42	14
map04973	Carbohydrate digestion and absorption	5	19	4	15	0	27	2	53	0	10	3	46	0	18	21	1	2	3	44	11	17	40	9	0
map04974	Protein digestion and absorption	5	16	8	20	5	16	9	69	10	9	0	29	0	12	29	4	9	20	89	40	25	120	23	9
map05146	Amoebiasis	8	26	28	57	3	34	19	41	1	20	4	54	2	28	38	10	14	14	97	26	26	68	27	10
map05150	Staphylococcus aureus infection	6	21	55	33	13	39	18	38	4	0	24	43	5	10	37	22	16	48	21	5	21	16	8	4
map05030	Cocaine addiction	5	23	31	33	9	46	25	107	0	19	1	49	0	2	61	3	2	9	85	42	23	92	32	7
map05152	Tuberculosis	178	236	838	215	180	242	84	180	218	297	92	388	154	261	209	84	64	177	171	128	120	177	140	66
map05031	Amphetamine addiction	6	23	43	45	12	46	24	100	0	8	1	59	0	23	65	3	2	16	88	37	23	95	32	9
map00380	Tryptophan metabolism	530	829	1202	677	436	941	230	268	185	152	237	1213	197	82	252	268	263	293	394	385	394	549	411	329
map00260	"Glycine, serine and threonine metabolism"	657	1291	1498	1031	457	1394	315	430	193	223	310	1737	209	137	307	311	424	357	597	584	474	648	602	402
map00261	Monobactam biosynthesis	138	228	302	193	95	269	55	74	68	22	54	349	48	14	85	63	60	89	86	98	80	116	126	73
map01230	Biosynthesis of amino acids	1967	3963	4742	3190	1567	4273	1063	1182	646	758	987	5243	675	456	1090	1119	1234	1186	1700	1634	1519	1911	1885	1328
map01110	Biosynthesis of secondary metabolites	5603	10263	12135	8559	4122	10951	2615	3236	1884	1961	2167	14195	1788	1103	2749	2819	3034	2829	4918	4271	4221	5467	4957	3551
map03410	Base excision repair	221	515	796	380	270	417	131	224	148	255	105	571	120	178	222	137	164	191	247	198	177	297	209	157
map00020	Citrate cycle (TCA cycle)	467	967	1048	645	367	941	277	255	125	110	199	1184	147	186	294	268	220	262	421	401	367	436	420	342
map04621	NOD-like receptor signaling pathway	50	78	120	108	30	123	33	86	20	25	22	154	15	37	74	28	27	126	115	60	56	117	77	29
map04622	RIG-I-like receptor signaling pathway	6	9	13	9	9	8	2	18	1	0	1	24	1	19	19	0	14	25	32	7	17	39	3	3
map04068	FoxO signaling pathway	57	126	106	98	29	111	41	122	23	19	19	211	19	34	43	20	43	20	135	66	66	98	80	26
map00940	Phenylpropanoid biosynthesis	19	56	50	66	9	39	20	9	12	19	3	92	20	5	3	4	10	3	21	6	11	10	20	9
map04626	Plant-pathogen interaction	90	184	212	206	52	216	55	39	39	35	34	274	29	25	47	50	40	102	81	71	68	99	93	51
map04745	Phototransduction - fly	1	0	8	14	3	2	17	84	0	18	1	21	2	26	38	7	13	1	117	25	38	82	38	10
map04725	Cholinergic synapse	1	0	42	9	4	0	68	182	2	60	19	31	2	68	73	9	16	30	105	43	31	131	50	17
map04740	Olfactory transduction	1	0	3	10	3	0	19	45	8	19	0	18	0	9	21	0	7	90	62	19	9	54	11	4
map04066	HIF-1 signaling pathway	88	175	199	215	74	181	30	91	28	23	41	288	16	28	60	36	40	58	164	124	80	149	87	62
map04720	Long-term potentiation	1	0	44	17	4	0	58	166	2	52	18	33	2	72	103	6	12	8	87	47	38	137	47	20
map05034	Alcoholism	9	29	53	72	12	51	55	202	9	32	12	104	7	46	73	16	9	23	125	65	32	143	55	15
map04070	Phosphatidylinositol signaling system	53	84	127	87	34	87	26	141	18	43	25	141	18	38	71	29	33	38	139	66	79	126	43	32
map04071	Sphingolipid signaling pathway	52	20	641	17	95	14	52	186	190	252	52	137	112	258	175	24	31	136	123	66	79	146	90	16
map04072	Phospholipase D signaling pathway	60	38	706	35	100	20	115	333	195	315	71	133	122	281	223	32	47	161	236	115	105	261	126	36
map05161	Hepatitis B	31	43	47	57	14	46	10	56	5	19	16	72	8	17	38	13	16	54	113	46	46	85	27	17
map05160	Hepatitis C	31	43	44	64	14	46	9	59	5	18	16	85	8	17	34	13	8	29	81	43	36	73	31	11
map05163	Human cytomegalovirus infection	31	43	88	90	15	53	67	180	7	75	31	110	10	74	97	19	18	35	152	85	55	178	80	30
map00270	Cysteine and methionine metabolism	724	1262	1449	1023	454	1374	304	387	210	191	302	1663	178	145	376	353	318	372	531	465	449	571	552	369
map05165	Human papillomavirus infection	18	43	44	79	9	56	47	340	12	49	9	144	20	41	73	31	50	68	358	146	86	373	58	68
map01240	Biosynthesis of cofactors	2181	3941	4598	3433	1500	4298	857	1153	729	799	750	5327	680	377	892	1029	1102	966	1876	1700	1720	2117	1829	1337
map01120	Microbial metabolism in diverse environments	4381	7854	9994	6659	3422	8643	2223	2360	1501	1560	1885	11051	1525	1073	2221	2440	2485	2289	3479	3285	2958	4302	3536	2776
map03420	Nucleotide excision repair	244	620	535	421	201	537	167	132	90	169	141	617	94	79	146	148	176	152	229	206	172	304	178	200
map00030	Pentose phosphate pathway	370	658	867	635	315	686	220	236	162	159	204	1017	152	47	186	234	275	172	263	256	255	378	287	219
map05168	Herpes simplex virus 1 infection	31	44	48	82	15	50	12	153	5	30	17	72	8	15	54	15	18	312	138	50	52	187	32	24
map05162	Measles	31	43	45	75	14	48	9	47	5	38	21	88	8	8	39	16	9	41	55	36	31	58	34	14
map05167	Kaposi sarcoma-associated herpesvirus infection	31	43	49	88	14	53	14	80	5	23	13	109	8	13	45	15	11	44	94	53	38	99	35	15
map00950	Isoquinoline alkaloid biosynthesis	47	110	132	94	42	142	28	51	11	4	43	176	14	8	58	32	29	36	64	61	46	53	41	37
map00830	Retinol metabolism	78	85	110	108	31	136	20	68	20	19	14	187	12	12	25	13	17	37	80	53	55	98	42	54
map00710	Carbon fixation in photosynthetic organisms	253	456	585	478	175	484	144	148	86	87	139	689	95	66	150	124	145	107	192	158	164	177	189	136
map04750	Inflammatory mediator regulation of TRP channels	1	0	44	14	4	0	54	141	2	61	18	28	2	78	76	8	12	23	87	32	34	105	52	19
map05164	Influenza A	31	43	44	79	14	48	15	85	5	32	20	94	8	8	49	13	14	44	129	65	52	101	26	24
map05166	Human T-cell leukemia virus 1 infection	4	13	56	70	7	8	58	231	2	76	25	71	5	68	116	9	47	89	191	86	58	225	48	24
map05169	Epstein-Barr virus infection	31	43	51	88	14	50	11	81	5	28	21	104	8	6	31	14	8	73	94	41	38	84	45	23
map04080	Neuroactive ligand-receptor interaction	4	11	19	8	3	5	73	294	0	48	7	19	3	34	145	7	50	59	282	123	91	290	65	26
map05170	Human immunodeficiency virus 1 infection	31	43	58	86	14	50	10	65	5	30	13	104	8	22	60	15	9	58	90	50	41	106	38	15
map05171	Coronavirus disease - COVID-19	14	2	21	213	4	34	13	78	0	10	0	223	1	0	39	0	4	116	111	43	55	114	30	3
map00280	"Valine, leucine and isoleucine degradation"	759	1233	1765	856	600	1392	338	410	284	282	345	1641	261	121	382	398	390	448	578	532	544	770	626	556
map00281	Geraniol degradation	129	212	360	170	113	250	75	43	82	105	56	316	66	32	66	113	105	76	139	113	103	153	129	96
map01250	Biosynthesis of nucleotide sugars	568	1081	1155	975	454	1171	273	324	161	230	222	1600	196	102	236	318	323	260	465	442	428	593	497	335
map00040	Pentose and glucuronate interconversions	152	346	429	400	155	476	78	139	44	79	74	569	63	40	105	130	139	100	175	148	129	209	144	87
map03430	Mismatch repair	346	828	759	597	236	774	190	169	125	201	187	995	107	97	176	179	220	228	299	262	252	386	261	234
map04520	Adherens junction	1	1	8	39	0	2	11	109	0	17	0	20	0	4	36	5	25	12	118	31	30	113	12	10
map00960	"Tropane, piperidine and pyridine alkaloid biosynthesis"	68	142	176	99	64	166	29	54	20	15	60	224	27	4	57	47	58	60	78	78	71	73	56	50
map00720	Carbon fixation pathways in prokaryotes	538	1117	1320	817	528	1181	310	306	159	181	287	1454	174	158	316	288	328	317	447	481	427	567	481	387
map00600	Sphingolipid metabolism	70	77	691	78	123	87	57	155	194	236	72	212	118	244	146	38	31	128	96	76	76	120	109	26
map00965	Betalain biosynthesis	16	22	31	34	4	34	7	10	2	10	1	29	1	0	4	3	17	7	26	32	15	16	7	18
map00966	Glucosinolate biosynthesis	35	92	116	81	32	113	30	19	18	24	16	109	10	4	28	28	25	24	41	42	41	52	49	35
map00603	Glycosphingolipid biosynthesis - globo and isoglobo series	7	16	40	33	0	28	7	23	9	10	9	43	1	2	19	3	13	4	39	19	11	39	15	7
map00604	Glycosphingolipid biosynthesis - ganglio series	7	6	32	17	0	14	6	15	0	9	3	26	1	2	13	0	7	4	29	14	10	36	12	7
map00290	"Valine, leucine and isoleucine biosynthesis"	290	570	742	437	276	654	191	188	108	129	156	731	122	72	177	166	175	211	278	232	218	262	274	176
map00051	Fructose and mannose metabolism	243	451	546	470	165	511	88	141	47	89	86	723	52	67	96	89	184	64	204	240	174	257	181	139
map03440	Homologous recombination	352	951	798	628	263	755	157	209	123	157	147	977	146	97	169	185	226	207	351	273	280	425	370	264
map03320	PPAR signaling pathway	309	498	670	363	246	548	155	216	140	103	137	665	110	99	208	176	168	180	332	236	231	378	279	245
map00053	Ascorbate and aldarate metabolism	270	314	516	368	184	429	109	156	123	110	77	555	72	45	94	129	150	146	165	147	112	220	136	122
map00052	Galactose metabolism	229	420	375	420	173	469	99	143	48	77	54	676	63	44	73	103	119	88	145	104	100	191	135	86
map04530	Tight junction	1	0	7	50	1	3	36	228	0	55	8	55	0	25	51	3	26	26	309	79	66	290	68	54
map00970	Aminoacyl-tRNA biosynthesis	441	1021	1051	811	337	1012	235	302	161	274	180	1204	159	139	246	260	245	244	460	335	382	505	422	322
map00730	Thiamine metabolism	220	318	311	283	128	397	70	73	60	84	70	474	36	35	52	90	102	65	154	122	145	203	174	107
map04657	IL-17 signaling pathway	18	25	39	49	13	37	6	32	6	6	12	57	7	18	36	6	15	79	47	30	30	46	30	13
map04659	Th17 cell differentiation	18	28	37	56	10	34	10	50	16	9	12	54	7	18	38	6	13	88	71	31	27	79	28	15
map00061	Fatty acid biosynthesis	394	693	839	545	342	720	162	218	161	107	128	917	100	85	216	160	203	164	352	272	321	379	289	250
map03450	Non-homologous end-joining	19	59	66	64	8	58	12	26	25	7	12	65	7	10	23	20	23	12	22	14	20	40	11	12
map00980	Metabolism of xenobiotics by cytochrome P450	247	348	468	351	182	445	97	126	53	54	78	547	57	30	111	108	98	126	165	116	136	193	126	140
map00860	Porphyrin metabolism	382	753	824	695	263	837	90	189	116	145	79	1143	114	39	112	160	179	185	346	371	336	357	379	244
map00982	Drug metabolism - cytochrome P450	243	360	479	352	187	478	95	121	51	54	77	561	57	30	104	108	98	117	160	118	131	203	140	142
map00620	Pyruvate metabolism	1004	1693	2119	1407	803	1984	491	488	374	312	457	2487	371	289	498	530	527	527	816	746	689	957	768	665
map00983	Drug metabolism - other enzymes	299	480	628	526	249	567	169	207	63	127	116	682	120	62	153	157	161	226	210	136	173	279	201	173
map00500	Starch and sucrose metabolism	367	716	746	695	216	751	187	172	109	145	110	1125	112	42	191	169	217	130	281	171	210	286	273	143
map00622	Xylene degradation	78	105	161	97	69	155	17	22	8	28	16	171	26	2	11	26	23	27	81	74	56	66	63	43
map00624	Polycyclic aromatic hydrocarbon degradation	52	69	130	72	63	91	50	54	16	64	48	112	25	11	47	53	36	50	34	27	23	53	22	31
map00625	Chloroalkane and chloroalkene degradation	229	256	403	292	113	381	43	53	79	46	47	475	51	10	53	79	74	69	143	130	109	191	128	144
map00626	Naphthalene degradation	92	110	160	126	44	169	22	23	22	5	28	213	12	9	22	22	23	10	81	70	56	88	68	75
map00627	Aminobenzoate degradation	274	385	560	306	208	407	148	132	140	90	117	543	110	40	165	155	121	130	174	148	144	228	171	121
map04666	Fc gamma R-mediated phagocytosis	63	20	649	24	95	11	46	130	190	259	52	134	112	237	175	24	25	123	99	58	64	84	70	11
map00740	Riboflavin metabolism	133	233	305	236	106	272	73	83	41	71	40	321	39	6	71	68	66	59	133	111	125	176	149	79
map00621	Dioxin degradation	32	40	90	53	25	78	9	11	4	1	21	77	8	9	11	18	8	7	50	35	22	36	37	29
map00981	Insect hormone biosynthesis	97	86	182	96	50	142	17	38	37	22	26	175	16	5	10	46	28	30	66	59	44	93	42	59
map00984	Steroid degradation	26	29	21	12	9	19	4	5	11	4	2	24	2	0	0	10	3	9	9	8	10	12	5	3
map00623	Toluene degradation	64	130	171	123	44	190	54	36	26	21	54	162	24	28	46	46	33	34	89	61	75	104	53	64
map00190	Oxidative phosphorylation	910	1485	1763	1306	737	1618	367	439	612	305	309	2338	334	244	366	466	409	495	711	656	721	814	710	523
map00071	Fatty acid degradation	761	1066	1586	823	602	1251	266	337	280	229	281	1597	198	94	314	346	349	340	600	509	497	833	587	559
map01040	Biosynthesis of unsaturated fatty acids	43	78	94	55	31	93	27	52	13	12	12	108	16	34	31	16	30	10	84	37	38	93	68	33
map02010	ABC transporters	2409	3755	5224	3440	1864	4899	1361	1427	854	698	1225	5664	878	537	1653	1387	1556	1482	1358	1468	1296	1820	1487	1217
map00195	Photosynthesis	106	248	214	215	102	256	59	45	49	30	47	314	43	34	48	64	50	59	79	92	94	114	85	92
map04310	Wnt signaling pathway	1	0	11	24	5	2	41	210	0	34	4	19	0	18	95	1	32	14	159	59	35	137	50	12
map00750	Vitamin B6 metabolism	93	214	228	148	59	204	58	82	25	22	30	291	17	17	48	52	58	52	86	80	76	78	65	65
map00630	Glyoxylate and dicarboxylate metabolism	871	1644	1897	1170	717	1666	458	491	205	287	428	2153	290	216	437	495	501	422	667	756	643	779	671	560
map00511	Other glycan degradation	9	49	59	79	1	69	12	38	0	15	3	105	0	2	19	0	7	7	68	41	27	74	31	16
map00633	Nitrotoluene degradation	27	75	70	74	11	44	5	7	20	1	6	110	4	3	7	12	5	12	24	10	17	23	22	14
map00513	Various types of N-glycan biosynthesis	2	6	22	31	0	14	15	45	0	24	3	26	0	6	23	6	11	0	67	24	24	101	12	15
map00998	Biosynthesis of various antibiotics	19	43	64	49	6	70	10	14	4	3	18	79	8	5	8	22	17	11	54	41	37	44	50	35
map00999	Biosynthesis of various plant secondary metabolites	65	114	135	135	38	139	25	24	26	18	26	229	15	0	25	25	38	35	64	30	46	43	48	50
map00997	Biosynthesis of various other secondary metabolites	18	36	48	23	8	27	4	4	5	0	1	47	5	1	4	3	3	1	26	9	16	17	28	23
map00514	Other types of O-glycan biosynthesis	9	10	16	5	1	10	2	52	0	13	1	12	1	1	9	0	1	16	62	16	15	89	6	4
map00512	Mucin type O-glycan biosynthesis	5	0	14	2	0	0	1	25	0	5	0	3	1	2	10	0	2	8	31	10	6	44	10	1
map00515	Mannose type O-glycan biosynthesis	9	10	5	4	1	10	12	55	0	7	0	10	1	6	22	0	4	5	50	24	20	61	5	6
map00996	Biosynthesis of various alkaloids	13	4	4	6	3	5	0	1	3	0	0	6	6	0	0	1	1	3	0	0	0	2	0	0
map01051	Biosynthesis of ansamycins	35	86	122	70	31	73	36	21	15	8	41	99	7	9	25	28	30	26	23	19	24	24	21	14
map02020	Two-component system	2067	3983	5064	2889	1728	4312	1119	1202	901	920	1028	5188	809	510	1256	1263	1684	1125	2095	2073	1960	2565	2148	1732
map01053	Biosynthesis of siderophore group nonribosomal peptides	30	45	73	43	31	40	5	4	16	0	1	67	26	0	7	1	2	0	29	25	27	28	17	16
map01054	Nonribosomal peptide structures	5	35	16	7	1	13	6	6	10	8	6	17	2	12	16	3	12	8	10	6	8	16	13	11
map01055	Biosynthesis of vancomycin group antibiotics	15	23	43	24	21	32	6	16	4	6	7	65	3	5	7	6	6	8	16	11	17	10	9	8
map02024	Quorum sensing	2128	3332	4794	2933	1739	4153	1465	1642	771	649	1215	4995	657	653	1724	1347	1196	1463	1126	1065	1045	1344	1011	927
map02025	Biofilm formation - Pseudomonas aeruginosa	386	620	867	408	343	707	196	202	198	259	143	813	222	77	203	289	378	216	418	418	402	562	453	411
map00760	Nicotinate and nicotinamide metabolism	306	632	746	515	267	755	124	211	104	129	108	871	109	110	174	178	175	198	271	308	280	347	313	214
map05415	Diabetic cardiomyopathy	250	312	560	387	258	369	92	203	367	127	59	964	120	105	152	90	106	151	264	174	185	287	201	121
map00400	"Phenylalanine, tyrosine and tryptophan biosynthesis"	278	558	669	474	245	684	148	179	90	118	163	789	116	60	169	193	219	196	263	240	297	299	304	235
map00640	Propanoate metabolism	514	1003	1233	742	436	1125	259	312	186	179	231	1283	202	126	299	274	298	335	463	421	393	514	449	356
map05418	Fluid shear stress and atherosclerosis	228	360	491	373	190	445	114	149	53	68	98	520	71	65	139	122	115	185	209	110	135	253	161	135
map00521	Streptomycin biosynthesis	115	200	255	198	101	262	44	83	36	51	55	321	33	17	57	50	77	46	100	77	103	103	105	63
map00643	Styrene degradation	159	209	390	177	139	285	71	64	45	31	77	322	26	28	126	79	83	69	104	101	111	148	92	80
map00520	Amino sugar and nucleotide sugar metabolism	477	958	1013	928	395	1020	220	324	121	189	171	1428	157	93	196	228	282	193	470	424	384	575	424	286
map05416	Viral myocarditis	31	43	56	75	16	48	31	92	7	20	15	56	8	12	19	15	14	23	110	67	40	105	45	21
map00401	Novobiocin biosynthesis	51	120	161	100	59	174	32	55	13	17	60	192	31	8	62	49	51	64	70	54	63	68	48	43
map02026	Biofilm formation - Escherichia coli	322	566	784	462	260	766	189	197	124	120	146	849	120	78	193	214	275	195	326	309	315	400	329	265
map00524	"Neomycin, kanamycin and gentamicin biosynthesis"	6	26	15	43	11	25	4	9	2	17	2	50	3	0	1	2	12	1	21	6	12	15	11	10
map00525	Acarbose and validamycin biosynthesis	30	43	69	36	30	75	8	18	12	6	12	94	5	5	22	7	7	12	17	20	21	17	17	10
map05417	Lipid and atherosclerosis	101	160	186	219	49	183	33	132	26	88	41	324	40	66	107	45	41	139	174	67	83	190	115	42
map00523	Polyketide sugar unit biosynthesis	67	82	106	78	56	136	18	37	19	27	32	141	22	5	32	22	23	26	39	31	46	49	67	23
map00404	Staurosporine biosynthesis	1	15	21	16	0	15	0	0	0	0	0	22	0	0	0	1	0	0	3	0	9	3	26	5
map00642	Ethylbenzene degradation	7	22	54	32	3	28	20	12	3	9	12	60	3	16	28	18	10	19	18	17	8	15	28	15
map00405	Phenazine biosynthesis	23	86	66	55	24	92	27	18	9	11	5	88	13	3	33	26	18	32	29	16	29	40	24	15
map05410	Hypertrophic cardiomyopathy	6	2	34	16	2	14	41	153	7	21	3	21	0	24	30	5	19	39	188	74	57	191	50	23
map02030	Bacterial chemotaxis	458	820	1041	655	368	913	288	268	208	198	234	1219	231	123	212	310	438	236	373	408	406	501	506	329
map04210	Apoptosis	36	63	59	67	27	65	23	119	10	30	25	124	11	26	50	20	33	34	129	66	62	141	48	47
map04211	Longevity regulating pathway	50	109	126	81	29	94	68	179	11	48	28	175	20	72	59	12	44	108	127	75	66	188	86	39
map04212	Longevity regulating pathway - worm	283	521	603	476	231	577	135	219	65	87	98	704	102	104	150	166	151	145	232	147	180	280	193	154
map00770	Pantothenate and CoA biosynthesis	375	695	918	581	282	753	202	250	166	130	188	970	116	68	171	235	207	203	333	275	245	417	288	225
map00650	Butanoate metabolism	665	1227	1549	939	626	1359	356	357	214	261	275	1607	248	155	347	403	375	385	580	450	518	676	524	462
map04214	Apoptosis - fly	70	100	94	86	29	102	23	88	17	31	33	128	16	33	24	23	24	47	102	56	46	104	56	27
map00410	beta-Alanine metabolism	289	440	646	382	207	544	101	132	127	107	97	667	88	54	105	157	141	152	252	217	208	340	238	192
map04216	Ferroptosis	130	195	190	144	116	187	50	97	67	38	47	244	30	21	66	54	67	52	109	81	69	142	79	76
map01501	beta-Lactam resistance	293	651	722	414	240	597	154	227	123	73	128	761	71	99	193	165	153	205	245	263	281	333	293	207
map01502	Vancomycin resistance	93	206	236	146	50	174	20	41	30	12	29	190	41	8	52	42	31	28	56	48	61	96	48	41
map01503	Cationic antimicrobial peptide (CAMP) resistance	184	413	507	299	195	457	132	173	65	63	108	521	42	87	164	135	148	168	206	206	223	222	305	165
map03008	Ribosome biogenesis in eukaryotes	21	39	37	72	19	38	18	44	13	19	13	94	9	12	29	11	12	66	53	47	23	93	34	12
map00531	Glycosaminoglycan degradation	23	41	207	36	38	42	22	239	26	144	24	89	11	155	155	2	18	75	87	47	35	70	35	27
map04213	Longevity regulating pathway - multiple species	140	250	305	203	116	204	82	228	34	108	65	372	50	92	77	33	72	44	191	114	103	236	139	69
map00533	Glycosaminoglycan biosynthesis - keratan sulfate	5	0	10	1	0	0	6	23	0	7	0	3	1	3	16	1	3	0	20	9	5	16	9	2
map04215	Apoptosis - multiple species	31	43	41	37	18	46	4	30	6	19	24	51	11	6	4	13	6	9	38	24	18	40	27	11
map04217	Necroptosis	78	139	207	202	57	202	35	83	10	20	41	341	23	23	55	16	53	122	144	85	64	137	107	44
map01059	Biosynthesis of enediyne antibiotics	3	1	3	3	1	7	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	3	0	0
map02040	Flagellar assembly	501	860	1011	683	353	1025	243	258	151	191	223	1130	172	132	289	272	273	237	423	424	373	485	398	318
map03010	Ribosome	541	1088	1006	1197	410	1338	183	337	177	173	174	1563	182	132	191	281	230	391	422	456	460	544	503	354
map00780	Biotin metabolism	273	527	599	403	201	509	123	139	75	64	91	559	62	37	126	126	133	101	269	195	254	269	215	179
map00660	C5-Branched dibasic acid metabolism	192	370	484	256	145	399	125	120	58	75	83	449	65	40	119	114	108	119	165	190	139	189	183	133
map00540	Lipopolysaccharide biosynthesis	228	429	589	350	184	483	130	117	97	126	111	610	88	39	93	185	188	165	254	197	208	291	256	257
map00541	O-Antigen nucleotide sugar biosynthesis	327	551	598	484	261	625	130	172	65	116	122	760	100	53	143	139	162	133	246	244	221	299	242	166
map00300	Lysine biosynthesis	280	521	588	416	181	556	128	171	102	87	114	650	96	54	158	135	126	164	208	212	158	269	213	164
map03018	RNA degradation	270	616	642	548	214	618	157	199	80	173	120	836	86	92	164	167	179	190	316	263	205	334	272	182
map00785	Lipoic acid metabolism	30	45	52	35	8	57	9	28	2	18	15	58	9	15	19	14	12	6	30	32	26	32	23	13
map00542	O-Antigen repeat unit biosynthesis	17	11	16	19	3	12	2	1	0	0	2	26	0	0	1	4	3	8	0	0	0	0	0	0
map03013	Nucleocytoplasmic transport	2	2	9	69	0	2	13	133	0	18	11	98	0	4	44	1	15	32	127	67	26	182	33	10
map03020	RNA polymerase	97	226	137	172	60	218	36	113	25	69	39	269	22	47	77	34	48	51	120	92	92	156	96	61
map04110	Cell cycle	11	8	127	42	45	2	25	138	10	67	5	49	9	28	40	7	20	34	119	57	21	132	27	13
map05200	Pathways in cancer	245	358	549	417	218	463	203	624	52	192	135	573	83	170	303	143	177	291	617	278	247	678	243	170
map00790	Folate biosynthesis	288	613	677	505	225	590	121	142	104	154	106	746	88	57	173	183	182	154	335	283	293	434	331	247
map00670	One carbon pool by folate	193	451	440	355	130	400	91	116	58	86	79	600	60	49	73	85	106	110	201	190	156	215	174	159
map00550	Peptidoglycan biosynthesis	336	744	758	613	261	823	142	150	110	73	117	844	108	89	199	157	160	175	270	278	289	344	300	210
map04112	Cell cycle - Caulobacter	348	562	644	522	213	636	78	125	90	47	69	746	85	51	69	123	112	97	141	158	132	221	175	119
map00310	Lysine degradation	404	674	928	557	345	752	191	245	146	159	186	937	144	101	177	212	227	253	386	348	345	536	328	313
map05206	MicroRNAs in cancer	39	98	74	67	15	71	49	202	26	30	29	89	5	31	56	25	34	62	179	95	45	195	48	24
map05204	Chemical carcinogenesis - DNA adducts	169	264	365	244	151	313	85	111	33	49	64	362	45	30	101	97	82	119	101	61	86	124	86	87
map01523	Antifolate resistance	66	131	127	104	43	112	38	58	29	29	25	205	21	18	26	26	39	30	74	69	47	62	52	48
map01524	Platinum drug resistance	232	402	497	332	199	435	103	148	67	96	106	520	67	68	126	137	114	132	171	120	128	188	117	119
map05207	Chemical carcinogenesis - receptor activation	187	288	434	308	167	344	160	351	41	111	95	447	54	111	180	106	107	201	299	141	152	318	158	122
map05208	Chemical carcinogenesis - reactive oxygen species	411	507	806	539	374	562	161	273	398	171	126	1198	163	154	254	176	189	237	325	200	233	352	219	171
map00311	Penicillin and cephalosporin biosynthesis	27	37	32	18	12	44	23	29	1	14	17	57	6	1	20	28	23	28	27	30	35	44	25	22
map05203	Viral carcinogenesis	21	48	43	96	11	52	31	110	14	35	13	154	23	54	34	32	23	98	172	76	36	136	64	53
map04914	Progesterone-mediated oocyte maturation	20	27	82	46	14	34	62	168	8	52	30	69	9	90	53	13	20	99	100	57	39	125	70	25
map04915	Estrogen signaling pathway	18	25	81	80	11	40	72	172	8	86	35	105	9	95	91	17	20	108	116	66	58	151	86	30
map04919	Thyroid hormone signaling pathway	31	51	95	56	45	77	74	267	17	58	27	111	20	67	87	40	51	73	258	111	95	266	79	43
map04910	Insulin signaling pathway	41	75	93	96	16	65	39	125	17	37	23	171	11	31	33	18	29	45	125	83	53	165	51	29
map04918	Thyroid hormone synthesis	34	54	139	70	28	47	69	164	13	66	31	102	10	68	88	24	30	18	134	74	64	140	89	40
map00430	Taurine and hypotaurine metabolism	125	234	279	144	91	286	97	79	50	49	80	401	37	37	129	95	101	122	145	120	97	202	130	115
map05205	Proteoglycans in cancer	12	27	52	85	20	25	63	232	4	45	5	84	6	34	78	12	39	50	296	107	87	278	31	41
map04111	Cell cycle - yeast	11	8	124	26	45	1	15	109	10	65	3	52	9	18	39	10	14	30	84	48	29	111	16	12
map05322	Systemic lupus erythematosus	5	7	16	32	3	12	26	101	9	29	11	32	7	33	48	13	7	20	56	22	12	56	27	10
map00791	Atrazine degradation	49	94	127	82	40	101	30	29	27	5	29	107	21	15	47	48	32	43	30	43	39	51	38	31
map04917	Prolactin signaling pathway	1	5	0	15	0	2	3	47	0	7	0	23	0	0	3	0	4	43	32	15	8	33	7	0
map04115	p53 signaling pathway	31	43	41	54	14	46	3	34	5	11	16	51	8	6	14	13	7	21	44	30	15	39	19	11
map02060	Phosphotransferase system (PTS)	61	159	157	184	49	201	31	29	36	21	27	267	33	0	14	41	72	35	33	62	54	60	70	39
map04916	Melanogenesis	5	1	52	24	4	6	84	200	2	64	19	46	2	72	93	4	33	11	131	63	46	137	53	31
map03030	DNA replication	267	780	728	500	251	656	124	213	117	182	126	819	101	69	160	151	183	183	293	243	224	388	234	198
map04113	Meiosis - yeast	60	87	239	70	94	54	37	159	25	85	19	150	14	27	38	12	20	28	115	58	30	151	31	22
map05210	Colorectal cancer	31	43	46	52	14	46	8	76	5	32	13	63	8	19	14	13	12	28	98	65	28	106	34	12
map04122	Sulfur relay system	168	355	366	255	85	322	53	76	57	38	50	367	45	44	80	91	94	66	132	115	110	124	153	112
map00680	Methane metabolism	486	913	1166	861	389	1080	272	304	136	220	216	1307	160	136	224	256	285	278	388	421	339	494	463	340
map04360	Axon guidance	1	1	19	20	3	0	64	213	0	61	7	41	0	18	66	1	39	14	233	85	71	199	45	6
map00561	Glycerolipid metabolism	218	355	487	362	132	404	60	143	84	82	68	552	60	36	61	114	100	105	229	180	178	275	165	174
map00562	Inositol phosphate metabolism	105	211	284	150	112	248	74	166	46	64	59	286	36	72	121	82	99	85	189	136	131	176	142	76
map05215	Prostate cancer	18	25	38	53	10	34	10	92	6	18	12	61	7	29	40	9	18	74	108	47	38	89	32	11
map00564	Glycerophospholipid metabolism	350	566	694	507	263	673	147	257	135	123	97	796	110	43	180	184	191	190	342	305	278	402	348	201
map04920	Adipocytokine signaling pathway	120	195	195	126	105	184	63	134	72	37	49	232	26	24	103	63	72	142	156	100	89	189	95	78
map04922	Glucagon signaling pathway	100	185	194	219	52	205	66	95	30	54	41	333	37	77	60	49	55	57	155	99	82	153	86	83
map00440	Phosphonate and phosphinate metabolism	92	135	227	118	54	188	58	39	12	23	43	234	23	5	48	57	49	58	85	86	61	91	60	71
map00565	Ether lipid metabolism	34	59	94	21	47	78	37	78	17	27	32	80	20	31	56	42	32	42	77	34	49	79	39	33
map05219	Bladder cancer	11	11	25	26	15	20	23	22	8	19	19	26	8	14	8	12	13	19	35	22	5	39	13	8
map04361	Axon regeneration	10	18	34	41	6	22	41	198	3	33	9	27	8	26	38	11	22	27	169	85	48	202	31	9
map04120	Ubiquitin mediated proteolysis	2	4	15	87	8	5	24	123	8	11	7	102	4	37	38	1	20	32	165	38	43	211	39	6
map04925	Aldosterone synthesis and secretion	1	0	43	11	4	1	63	159	12	56	21	37	2	68	71	6	12	21	122	51	37	137	56	24
map05211	Renal cell carcinoma	17	25	40	32	16	40	8	51	4	13	7	41	9	24	22	9	20	16	48	36	28	67	16	12
map04924	Renin secretion	6	2	34	15	0	13	20	81	3	13	0	29	0	39	42	8	11	15	55	17	34	92	25	8
map04921	Oxytocin signaling pathway	1	3	56	44	10	5	69	207	2	69	22	68	2	72	73	11	18	30	182	64	52	212	55	25
map05214	Glioma	1	0	5	10	3	0	2	37	0	4	0	23	0	11	17	0	2	5	70	34	12	55	5	1
map04911	Insulin secretion	1	0	40	8	4	0	63	197	2	67	18	34	2	70	68	6	20	18	116	49	31	140	53	20
map04912	GnRH signaling pathway	1	0	43	14	4	0	62	174	2	68	21	43	2	79	89	9	19	20	131	44	39	161	55	19
map05202	Transcriptional misregulation in cancer	1	0	9	41	1	2	42	175	5	47	7	19	4	51	39	11	20	34	156	37	37	133	30	11
map04114	Oocyte meiosis	2	2	72	38	11	1	58	203	2	65	18	63	2	55	56	9	15	37	96	55	35	151	51	18
map04370	VEGF signaling pathway	52	20	642	19	95	14	46	106	190	239	51	104	112	228	151	21	19	120	64	49	41	50	68	9
map04371	Apelin signaling pathway	52	23	693	21	102	12	100	286	197	291	75	143	114	305	207	27	39	164	196	114	96	218	123	26
map05340	Primary immunodeficiency	13	35	21	45	10	34	4	7	6	3	10	32	2	2	7	14	12	10	36	15	16	26	20	11
map04011	MAPK signaling pathway - yeast	26	60	49	50	24	49	14	34	4	17	7	181	16	1	33	7	25	8	47	34	20	45	29	17
map05222	Small cell lung cancer	31	43	45	41	18	49	8	46	6	11	16	52	11	6	40	14	10	18	112	43	30	95	29	14
map04013	MAPK signaling pathway - fly	24	49	54	83	4	45	38	155	5	68	7	108	3	31	60	9	20	31	173	78	47	152	44	14
map00450	Selenocompound metabolism	238	414	444	304	170	445	107	126	59	72	96	609	50	95	144	126	95	138	178	126	135	211	183	112
map00330	Arginine and proline metabolism	494	818	1194	784	386	1096	225	357	171	133	267	1310	122	61	333	289	318	247	383	390	382	457	459	265
map04016	MAPK signaling pathway - plant	86	180	164	155	73	148	36	62	37	22	36	245	35	18	61	48	49	48	75	52	61	69	51	48
map04930	Type II diabetes mellitus	20	43	35	41	9	49	11	51	12	22	4	94	20	25	4	27	21	49	68	41	26	80	21	31
map00333	Prodigiosin biosynthesis	146	243	337	185	98	236	58	78	39	42	43	330	34	22	90	61	69	63	123	102	140	158	119	93
map04932	Non-alcoholic fatty liver disease	101	106	176	140	110	122	41	100	152	71	35	360	57	55	62	30	36	139	115	84	75	128	74	46
map00332	Carbapenem biosynthesis	25	63	78	44	10	64	8	11	15	13	14	59	5	8	13	9	18	10	18	16	22	15	32	13
map04934	Cushing syndrome	90	52	489	33	109	54	125	387	110	282	85	127	63	318	222	43	79	142	283	137	78	298	122	44
map04012	ErbB signaling pathway	1	0	15	7	3	0	8	53	0	9	2	12	0	12	17	0	5	10	80	30	12	74	14	0
map04936	Alcoholic liver disease	264	332	575	261	170	444	89	184	104	83	94	570	68	107	140	127	103	226	314	228	222	373	230	232
map04931	Insulin resistance	48	92	103	98	31	111	33	140	27	33	17	186	28	15	44	21	39	41	113	52	61	150	57	32
map05225	Hepatocellular carcinoma	178	265	393	275	165	344	123	281	34	86	72	409	54	46	144	105	122	110	281	146	134	285	108	98
map05100	Bacterial invasion of epithelial cells	2	5	2	42	0	12	12	77	0	19	0	53	0	0	18	3	2	44	93	25	33	91	16	14
map00571	Lipoarabinomannan (LAM) biosynthesis	0	18	3	3	0	10	0	0	0	0	0	10	0	0	0	0	0	0	5	0	3	0	1	0
map04137	Mitophagy - animal	0	1	1	39	0	3	10	18	0	10	0	60	4	0	6	0	7	6	26	15	14	58	12	4
map03050	Proteasome	0	3	11	38	0	0	6	28	0	5	0	64	0	0	3	0	2	1	22	12	7	42	0	3
map05321	Inflammatory bowel disease	0	3	0	9	0	0	1	9	10	0	0	0	0	0	3	0	0	10	4	4	1	10	0	2
map00100	Steroid biosynthesis	0	1	4	14	0	3	0	16	0	13	0	25	0	0	0	0	0	0	18	21	20	28	21	17
map05110	Vibrio cholerae infection	0	13	6	33	0	12	12	64	0	5	0	52	0	1	19	1	11	9	79	27	27	93	5	19
map04390	Hippo signaling pathway	0	1	6	30	1	2	41	223	0	23	1	46	0	8	48	3	37	25	178	48	59	196	12	18
map04392	Hippo signaling pathway - multiple species	0	1	14	0	1	0	17	110	0	13	4	9	0	10	58	1	27	36	91	27	33	90	22	4
map04710	Circadian rhythm	0	3	1	11	0	0	2	28	10	2	2	4	0	0	5	0	2	12	14	4	3	21	3	2
map04391	Hippo signaling pathway - fly	0	1	3	19	1	2	38	208	0	25	4	36	0	11	81	1	42	38	201	50	70	200	25	23
map04962	Vasopressin-regulated water reabsorption	0	5	0	9	0	0	6	10	0	4	0	17	0	1	10	0	0	0	25	11	10	43	9	2
map04721	Synaptic vesicle cycle	0	5	8	19	0	0	25	119	0	9	0	53	0	13	31	2	7	25	76	44	32	131	12	7
map05140	Leishmaniasis	0	2	8	32	0	5	1	15	0	10	0	33	0	0	20	0	1	30	24	15	12	27	6	5
map00944	Flavone and flavonol biosynthesis	0	3	0	3	0	0	0	7	0	0	0	1	0	0	0	0	0	12	0	0	0	0	0	0
map04624	Toll and Imd signaling pathway	0	1	0	19	2	0	3	41	2	15	0	16	0	5	29	0	1	15	39	17	17	47	5	5
map00941	Flavonoid biosynthesis	0	6	4	12	0	2	0	5	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0
map00945	"Stilbenoid, diarylheptanoid and gingerol biosynthesis"	0	6	4	11	0	2	0	5	0	0	0	3	0	1	0	0	0	0	0	0	0	0	0	0
map00140	Steroid hormone biosynthesis	0	2	6	21	0	5	10	38	0	2	0	12	0	7	4	4	1	41	31	8	17	39	6	7
map04640	Hematopoietic cell lineage	0	1	1	30	0	0	5	55	0	25	0	9	0	13	6	6	9	4	61	8	15	47	11	7
map03460	Fanconi anemia pathway	0	2	3	0	1	2	1	27	4	17	1	1	1	1	15	0	7	3	36	14	2	35	2	6
map00196	Photosynthesis - antenna proteins	0	1	0	0	0	7	0	0	0	0	0	6	0	0	0	0	0	0	1	1	3	1	2	8
map00510	N-Glycan biosynthesis	0	16	17	29	4	9	3	32	0	6	3	15	0	2	2	0	0	0	57	13	12	76	6	5
map04320	Dorso-ventral axis formation	0	6	10	4	0	0	10	110	0	15	5	7	0	31	10	0	4	70	49	31	23	63	9	9
map03240	Viral replication	0	13	0	0	0	4	0	0	0	0	0	3	0	0	0	0	1	0	0	0	0	0	0	0
map01052	Type I polyketide structures	0	4	4	0	0	1	0	2	0	0	0	2	0	0	1	1	1	0	0	0	0	0	0	0
map04350	TGF-beta signaling pathway	0	1	6	16	0	0	15	62	0	2	0	8	0	1	23	4	8	7	71	34	10	79	4	2
map03022	Basal transcription factors	0	8	15	4	2	3	15	21	2	4	6	7	0	19	23	14	9	46	24	17	2	15	6	5
map03040	Spliceosome	0	3	10	78	1	2	33	201	0	38	21	89	0	28	61	7	34	198	169	72	46	188	35	20
map04010	MAPK signaling pathway	0	1	36	39	1	7	39	169	0	55	5	52	0	77	52	15	13	110	219	75	67	222	47	18
map00232	Caffeine metabolism	0	0	4	0	0	0	5	6	0	0	0	2	0	0	4	0	0	3	7	5	3	6	3	1
map04960	Aldosterone-regulated sodium reabsorption	0	0	5	7	0	0	1	8	0	7	0	27	0	0	7	0	4	1	30	7	6	7	4	1
map04961	Endocrine and other factor-regulated calcium reabsorption	0	0	2	21	0	0	15	26	5	6	3	33	0	17	24	0	0	7	50	19	23	39	15	6
map04966	Collecting duct acid secretion	0	0	1	14	0	0	1	22	0	0	0	19	0	0	0	1	0	2	13	4	3	28	0	0
map04611	Platelet activation	0	0	51	31	7	2	67	187	2	59	20	38	2	68	59	11	18	25	149	64	41	171	60	26
map04730	Long-term depression	0	0	8	9	0	0	19	46	0	22	0	16	0	28	34	4	3	13	69	26	17	69	10	0
map04610	Complement and coagulation cascades	0	0	1	3	0	0	0	15	0	8	0	9	0	0	3	0	0	10	35	6	7	34	4	1
map04742	Taste transduction	0	0	34	0	1	0	62	164	5	50	18	19	2	47	65	7	12	9	74	51	36	110	36	19
map04744	Phototransduction	0	0	2	6	0	0	2	5	0	5	0	12	0	0	12	0	5	1	9	4	3	15	3	2
map04625	C-type lectin receptor signaling pathway	0	0	19	13	0	4	8	24	0	7	0	24	1	7	38	4	0	41	30	9	12	33	12	3
map04510	Focal adhesion	0	0	28	43	6	4	22	158	0	46	2	39	0	48	47	8	21	21	257	85	34	241	43	16
map04650	Natural killer cell mediated cytotoxicity	0	0	14	16	0	0	0	15	0	11	0	11	0	12	19	0	0	11	23	11	7	20	5	6
map04658	Th1 and Th2 cell differentiation	0	0	4	16	5	0	1	53	0	3	5	20	0	2	27	0	1	15	50	13	20	37	16	4
map04540	Gap junction	0	0	42	28	1	0	65	243	2	64	18	59	5	79	93	11	21	18	151	72	51	158	58	27
map04660	T cell receptor signaling pathway	0	0	11	21	0	0	3	23	0	12	0	29	0	1	27	0	4	16	38	20	15	22	9	0
map04668	TNF signaling pathway	0	0	4	8	0	3	5	39	0	0	0	12	4	17	29	0	2	24	54	19	16	29	9	12
map04550	Signaling pathways regulating pluripotency of stem cells	0	0	3	11	0	0	52	205	0	29	5	17	0	28	65	3	40	10	148	57	56	163	7	3
map05414	Dilated cardiomyopathy	0	0	54	14	3	2	91	250	9	68	19	26	2	75	60	9	26	39	220	96	56	241	76	39
map05412	Arrhythmogenic right ventricular cardiomyopathy	0	0	15	17	2	2	24	85	7	12	0	16	0	19	11	3	14	50	104	25	29	113	15	11
map04330	Notch signaling pathway	0	0	14	3	5	0	9	94	0	4	12	11	0	14	16	1	5	19	68	16	14	44	18	16
map04218	Cellular senescence	0	0	6	35	2	1	14	65	0	10	0	45	0	21	15	2	7	42	92	40	17	122	7	3
map04340	Hedgehog signaling pathway	0	0	1	7	0	2	13	78	0	15	1	13	0	34	20	1	10	2	60	17	17	53	15	0
map04341	Hedgehog signaling pathway - fly	0	0	1	12	0	2	5	34	0	6	1	9	0	14	7	0	1	3	34	13	15	21	9	0
map03015	mRNA surveillance pathway	0	0	2	29	0	9	9	81	0	8	0	65	0	1	35	0	10	29	50	40	14	85	12	8
map05323	Rheumatoid arthritis	0	0	1	22	0	0	1	22	0	2	0	23	0	1	1	1	0	16	13	15	5	40	0	0
map05213	Endometrial cancer	0	0	4	8	0	0	3	54	0	15	0	18	0	11	11	3	10	3	55	35	12	48	7	0
map05216	Thyroid cancer	0	0	3	14	0	0	6	16	0	4	0	4	0	11	7	0	3	6	23	8	7	14	1	1
map05217	Basal cell carcinoma	0	0	1	3	0	0	22	103	0	15	1	7	0	4	29	1	19	3	83	24	28	79	5	2
map05218	Melanoma	0	0	3	5	0	0	0	19	0	1	0	6	0	11	5	0	0	1	26	21	4	10	4	0
map05212	Pancreatic cancer	0	0	5	14	0	0	3	42	0	21	1	17	0	17	20	2	7	13	74	42	12	79	15	4
map05224	Breast cancer	0	0	12	11	6	2	33	218	3	25	7	27	1	17	53	1	23	54	174	63	43	169	17	10
map04014	Ras signaling pathway	0	0	30	22	0	0	32	166	0	41	3	31	0	54	105	8	14	37	167	63	52	191	43	21
map04139	Mitophagy - yeast	0	0	9	8	0	0	4	26	7	19	0	45	0	10	14	0	2	10	43	16	6	55	9	2
map05220	Chronic myeloid leukemia	0	0	10	8	0	0	6	45	0	4	2	11	0	23	21	1	4	14	56	25	16	39	2	4
map05226	Gastric cancer	0	0	9	16	0	2	32	164	0	24	2	15	0	15	54	4	22	12	138	59	37	155	16	2
map05223	Non-small cell lung cancer	0	0	3	7	0	0	0	35	0	8	0	24	0	11	12	0	10	4	47	31	10	32	4	0
map04130	SNARE interactions in vesicular transport	0	0	2	7	0	0	1	6	0	0	0	11	0	0	2	0	0	0	9	8	2	32	1	5
map04015	Rap1 signaling pathway	0	0	57	53	1	3	83	297	12	81	18	53	2	95	139	9	17	35	235	90	66	283	75	34
map05221	Acute myeloid leukemia	0	0	3	16	0	0	7	41	0	9	3	8	0	11	8	0	5	8	61	31	10	64	1	0
map04136	Autophagy - other	0	0	1	9	0	0	2	23	0	0	0	23	0	7	3	2	4	5	48	22	8	65	12	2
map04380	Osteoclast differentiation	0	0	9	16	0	0	3	13	0	5	1	12	1	0	24	0	7	52	15	13	16	27	7	4
map04022	cGMP-PKG signaling pathway	0	0	58	30	7	0	93	276	7	69	23	78	2	100	96	10	33	66	188	113	65	233	67	30
map04140	Autophagy - animal	0	0	6	41	0	5	7	66	0	12	2	53	0	14	16	7	11	32	83	51	35	132	24	3
map04145	Phagosome	0	0	2	63	0	4	22	143	0	18	0	90	3	7	34	10	7	21	149	63	58	200	24	17
map04270	Vascular smooth muscle contraction	0	0	55	26	7	0	74	238	2	88	26	37	2	93	90	12	25	27	176	93	60	242	92	40
map05144	Malaria	0	0	1	6	0	0	0	14	0	16	0	3	0	0	0	3	0	4	15	9	6	28	4	0
map04060	Cytokine-cytokine receptor interaction	0	0	2	10	0	0	10	16	0	0	0	4	0	0	14	3	7	18	16	7	13	43	0	2
map04062	Chemokine signaling pathway	0	0	52	30	1	0	64	173	2	76	18	39	2	86	87	6	22	19	107	48	47	136	61	17
map05032	Morphine addiction	0	0	46	9	1	0	72	210	5	81	20	28	2	70	79	5	21	19	122	51	35	132	64	24
map05033	Nicotine addiction	0	0	2	0	0	0	12	99	0	3	1	1	0	9	42	1	3	16	70	20	20	74	28	2
map04064	NF-kappa B signaling pathway	0	0	4	15	0	3	0	22	0	3	0	6	1	2	26	0	3	50	18	8	17	27	3	2
map01521	EGFR tyrosine kinase inhibitor resistance	0	0	13	17	0	0	8	63	0	8	0	14	0	25	13	0	6	20	74	29	21	79	14	1
map01522	Endocrine resistance	0	0	45	8	6	0	54	191	2	60	23	37	2	74	52	4	13	23	133	66	30	146	58	18
map04913	Ovarian steroidogenesis	0	0	47	4	1	3	60	117	2	51	18	10	2	51	48	4	11	16	63	30	22	92	43	16
map04923	Regulation of lipolysis in adipocytes	0	0	51	12	1	3	74	174	2	56	18	18	2	75	66	5	17	20	89	58	23	116	45	23
map04926	Relaxin signaling pathway	0	0	38	14	1	0	70	172	2	56	18	39	2	53	97	7	11	20	114	64	47	159	57	19
map04927	Cortisol synthesis and secretion	0	0	43	3	1	0	61	137	2	53	20	11	2	70	52	6	16	20	68	42	25	104	51	17
map04928	"Parathyroid hormone synthesis, secretion and action"	0	0	47	15	1	0	71	193	2	77	21	39	2	79	98	8	17	27	114	54	38	148	56	24
map04929	GnRH secretion	0	0	2	7	0	2	12	64	0	11	0	10	0	37	20	2	9	6	68	29	25	69	16	1
map04935	"Growth hormone synthesis, secretion and action"	0	0	40	11	1	1	67	192	2	65	19	34	2	69	64	6	26	83	147	62	43	146	55	18
map04933	AGE-RAGE signaling pathway in diabetic complications	0	0	2	15	0	0	6	78	0	24	7	19	0	28	48	5	7	17	65	39	27	65	12	9
map04712	Circadian rhythm - plant	0	0	0	7	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0	0	0	0	0
map00253	Tetracycline biosynthesis	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
map04620	Toll-like receptor signaling pathway	0	0	0	21	0	2	1	18	0	8	0	8	0	0	25	0	0	30	19	12	15	18	6	0
map04623	Cytosolic DNA-sensing pathway	0	0	0	1	0	0	0	8	0	0	0	3	0	0	22	0	1	17	20	6	18	10	1	3
map04630	JAK-STAT signaling pathway	0	0	0	5	0	0	7	50	0	1	3	7	0	0	4	0	3	24	59	27	11	55	7	3
map04512	ECM-receptor interaction	0	0	0	10	0	2	6	71	0	20	0	2	0	16	30	7	14	20	132	40	19	134	14	8
map04514	Cell adhesion molecules	0	0	0	18	0	0	36	85	0	19	0	3	0	14	23	1	9	11	96	38	16	105	9	8
map04662	B cell receptor signaling pathway	0	0	0	10	0	0	0	23	0	8	0	15	0	0	23	1	0	13	16	6	11	14	6	0
map04664	Fc epsilon RI signaling pathway	0	0	0	11	0	0	5	18	0	12	0	15	0	0	15	0	5	14	23	8	9	10	9	0
map00062	Fatty acid elongation	0	0	0	1	0	0	6	26	0	2	1	13	0	6	1	0	2	5	23	3	4	31	4	0
map04670	Leukocyte transendothelial migration	0	0	0	50	0	2	10	47	0	10	0	23	0	0	24	4	2	8	84	19	13	77	13	10
map04672	Intestinal immune network for IgA production	0	0	0	8	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0
map00073	"Cutin, suberine and wax biosynthesis"	0	0	0	2	0	0	0	6	0	0	0	4	0	0	0	0	0	2	5	0	0	1	0	0
map01056	Biosynthesis of type II polyketide backbone	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
map05310	Asthma	0	0	0	6	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0
map05320	Autoimmune thyroid disease	0	0	0	6	0	0	5	12	0	0	0	0	0	0	11	1	4	6	19	13	0	14	3	1
map05332	Graft-versus-host disease	0	0	0	6	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	4	0	0
map05330	Allograft rejection	0	0	0	6	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0
map05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	0	0	0	17	0	0	2	35	0	1	0	14	0	0	18	0	2	29	55	22	24	62	6	2
map00904	Diterpenoid biosynthesis	0	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0
map00902	Monoterpenoid biosynthesis	0	0	0	2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
map04061	Viral protein interaction with cytokine and cytokine receptor	0	0	0	10	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	5	0	0
map04075	Plant hormone signal transduction	0	0	0	24	0	0	0	0	0	0	0	22	0	0	0	0	0	0	0	0	0	0	0	0
map00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	0	0	0	1	0	0	5	20	0	7	0	0	1	0	4	0	2	0	35	5	0	19	9	7
map00532	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	0	0	0	1	0	0	7	44	0	15	3	0	0	6	7	0	13	1	41	12	9	42	5	1
map04950	Maturity onset diabetes of the young	0	0	0	0	0	0	20	43	0	8	7	8	0	0	29	2	9	0	29	21	17	45	4	6
map04711	Circadian rhythm - fly	0	0	0	0	0	0	1	20	0	11	0	5	0	1	2	0	3	0	7	0	3	20	6	0
map04977	Vitamin digestion and absorption	0	0	0	0	0	0	3	50	0	31	0	0	0	0	2	1	4	0	60	15	9	50	18	0
map00601	Glycosphingolipid biosynthesis - lacto and neolacto series	0	0	0	0	0	0	4	12	9	0	3	0	0	1	8	0	6	4	21	11	18	27	3	3
map00563	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	0	0	0	0	0	0	1	48	0	0	0	5	0	0	1	1	5	2	36	0	14	49	1	0
map00254	Aflatoxin biosynthesis	0	0	0	0	0	0	0	5	0	2	0	7	0	0	0	0	0	0	14	2	1	4	0	0